Table 4 Prescribed medicines (N% or mean (SD)/median (IQR)*
Medicine | PHOENIx participants |
|---|---|
|  | n = 128 |
Opiate substitution treatment | 115 (89.8%) |
 Methadone | 95 (74.2%) |
  Daily dose (mg) | 86.9 (29.4) |
 Buprenorphine oral/sublingual/with naloxone | 17 (13.3%) |
  Daily dose (mg)a | 16 (10–19.5) |
 Buprenorphine injection | 2 (1.6%) |
  Weekly dose (mg) | 96 (64–128) |
 Diamorphine injection | 1 (0.8%) |
  Daily dose (mg) | 300 (–) |
Diazepam treatment | 13 (10.2%) |
  Daily dose (mg) | 21.3 (8.9) |
Number of medicines for problem drug use | 1 (0–1) |
Any medicine for problem drug use | 115 (89.8%) |
Medicines for mental health problem | Â |
Any mental health medicine | 67 (52.3%) |
Number of medicines for mental health problem | 1 (0–1) |
Type of medicine for mental health problem | Â |
 Antipsychotic | 19 (14.8%) |
 Antidepressant | 53 (41.4%) |
 Anxiolyticb | 23 (17.9%) |
Medicines for physical health problem | Â |
Any medicine for physical health problem | 65 (50.8%) |
Number of medicines for physical health problem | 1 (0–2) |
Type of medicine for physical health problem | Â |
 Nutrition and anaemia | 21 (16.4%) |
 Analgesic | 32 (25.0%) |
 Topical for skin condition | 2 (1.6%) |
 Antiepileptic | 7 (5.5%) |
 Nocturnal leg cramps | 1 (0.8%) |
 Upper gastrointestinal | 11 (8.6%) |
 Laxative | 1 (0.8%) |
 Respiratory | 14 (10.9%) |
 Diabetes | 4 (3.1%) |
 Antiretroviral | 10 (7.8%) |
 Antibacterial/antifungal | 5 (3.9%) |
 Antiplatelet | 2 (1.6%) |
 Diuretic | 2 (1.6%) |
 Statin | 3 (2.3%) |
 Sex hormone | 1 (0.8%) |
 Antihypertensive | 5 (3.9%) |
 Hormone Replacement Therapy | 2 (1.6%) |
 Drug for movement disorder | 1 (0.8%) |
 COVID-19 vaccinec |  |
  None | 23 (18%) |
  Declined to answer question | 54 (42.2%) |
  1st dose only | 28 (21.9%) |
  1st and 2nd doses | 23 (18.0%) |